Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03062345 · ClinicalTrials.gov registry record · NA

In Home VR Therapy

A NA study, sponsored by Shirley Ryan AbilityLab.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT03062345 is a NA study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03062345, a NA study, has completed, sponsored by Shirley Ryan AbilityLab.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

Virtual reality is a video game in which a person and their real-time movements are represented on a screen in a virtual environment. This study will compare the use of multi-user virtual reality (VR) to single-user VR to determine if either provides superior engagement in upper extremity therapy and greater motivation to perform repetitive training. Stroke survivors will participate in a longitudinal study in which they will have the opportunity to perform rehabilitative training with multi-user VR and single-user VR modes in their homes. They will use each mode for 2 weeks, completing 4 session per week, each session is 1 hour long. Upper extremity motor control, level of engagement, and active range of motion will be assessed at time points during the intervention period. Subject evaluations will take place before the intervention, at the midpoint of intervention (between switching from multi-user to single-user modes, or vice versa), and at the end of the intervention. The investigators hope to address two aims: Aim 1: To determine if the use in-home multi-user virtual reality treatment results in greater engagement in therapy compared with in-home single user virtual reality treatment. Aim 2: To determine if in-home virtual reality treatment results in greater practice The investigators hypothesize that stroke survivors will be more engaged in therapy when training with the multi-user VR system and this will translate into greater practice.

Interventions

  • OTHER Single-User Virtual Reality Upper Extremity Therapy
  • OTHER Multi-User Virtual Reality Upper Extremity Therapy

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2017-01-26
Est. Completion 2020-05-30
Phase NA

Sponsor

Shirley Ryan AbilityLab

138 total trials

What the Registry Record Tells You About NCT03062345

The ClinicalTrials.gov registry entry for NCT03062345 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Single-User Virtual Reality Upper Extremity Therapy is the first listed.

NCT03062345 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03062345 about?

NCT03062345 is a clinical study titled "In Home VR Therapy". Virtual reality is a video game in which a person and their real-time movements are represented on a screen in a virtual environment. This study will compare the use of multi-user virtual reality (VR) to single-user VR to determine if either provides superior engagement in upper extremity therapy an...

What is the current status of trial NCT03062345?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-01-26. Estimated completion is 2020-05-30.

What interventions are being tested in trial NCT03062345?

The interventions under investigation include: Single-User Virtual Reality Upper Extremity Therapy (OTHER), Multi-User Virtual Reality Upper Extremity Therapy (OTHER).

Who is sponsoring clinical trial NCT03062345?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.